Carboxyhemoglobin pulse co-oximeter® Carboxyhemoglobin (SpCO®) is a breakthrough measurement that allows clinicians to noninvasively and immediately detect elevated levels of carbon monoxide in the blood—facilitating earlier diagnosis and treatment for patients poisoned by carbon monoxide. >> Exposure to carbon monoxide (CO) is the leading cause of death by poisoning in industrialized countries.1 >> CO poisoning is often misdiagnosed because symptoms are similar to the flu.2 >> Timely diagnosis and treatment of CO poisoning is critical.3 >> SpCO has been shown to identify 60% more carbon monoxide poisonings than traditional methods.4 “ Carboxyhemoglobin measurements performed noninvasively in the Emergency Department with Masimo Pulse CO-Oximetry should lead to enhanced diagnosis of CO poisoning, increased referral for appropriate treatment, and a resultant reduction in morbidity from the disease.” neil b. hampson, MD Pulmonologist, Department of Hyperbaric Medicine, Virginia Mason Medical Center, Seattle, Washington

Clinical accuracy SpCO (%) for Pulse CO-Oximetry >> In comparisons of SpCO readings with invasive carboxyhemoglobin (COHb) measurements taken at the same time and analyzed by a laboratory CO-Oximeter, SpCO was validated in the range of 1-40% with an accuracy of +3% at 1 standard deviation.* * Masimo FDA Submission Data © 2012 M asimo Corporation. A ll rights reserved. Proven accuracy compared to invasive > laboratory methods* Reference COHb (%) TECHNOLOGY PLATFORM Masimo rainbow SET® is a noninvasive monitoring platform enabling the assessment of multiple blood constituents and physiologic parameters...